NCT04377152Approved For Marketing不适用
Expanded Access: 68Gallium-PSMA-11 for PET Imaging of Prostate Cancer
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Approved For Marketing
- 试验地点
- 1
研究概览
简要总结
This expanded access protocol provides eligible participants with investigational 68Ga-PSMA-11 PET imaging to detect and localize prostate cancer for initial and subsequent treatment strategy.
研究设计
- 研究类型
- Expanded Access
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Age ≥ 18 years
- •Histopathologically confirmed or biopsy proven prostate adenocarcinoma.
- •Concern for metastatic disease in one of the following settings:
- •Initial staging with intermediate to high risk prostate cancer.
- •Biochemical recurrence after initial therapy.
- •Ability to understand a written informed consent document, and the willingness to sign it
排除标准
- •Unlikely to comply with protocol procedures, restrictions and requirements and judged by the Investigator to be unsuitable for participation
研究者
Thomas Hope
Principal Investigator
University of California, San Francisco
研究点 (1)
Loading locations...
相似试验
Approved For Marketing
不适用
Expanded Access Protocol of 68Ga-PSMA-11 for PET ImagingProstate CancerNCT04348682Jonsson Comprehensive Cancer Center
No Longer Available
不适用
Expanded Access to Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrent Prostate CancerProstate AdenocarcinomaNCT05415228Morand Piert, MD
No Longer Available
不适用
Expanded Access [Ga-68] PSMA-11 PET ImagingProstate CancerNCT04800068Mayo Clinic
已完成
3 期
68Ga-PSMA-11 PET/CT Screening Prior to 177Lu-PSMA-617 Therapy for Patients With Metastatic Castrate Resistant Prostate CancerCastration-Resistant Prostate CarcinomaMetastatic Prostate CarcinomaStage IVB Prostate Cancer AJCC v8NCT05547386Mayo Clinic163
No Longer Available
不适用
68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)Prostatic Neoplasms, Castration-ResistantProstatic NeoplasmsNCT04854369Tulane University